Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report
Firoozeh Sahebi(City Of Hope National Medical Center), Parameswaran Hari(Medical College of Wisconsin), Omar F. Dávila Alvelo, Laurent Garderet(Inserm), Nina Knelange(European Society for Blood and Marrow Transplantation), Harry C. Schouten, Anita D’Souza, James F. Sanchez(City of Hope), José L. Díez‐Martín(Universidad Complutense de Madrid), Abraham S. Kanate(HonorHealth), Qaiser Bashir(The University of Texas MD Anderson Cancer Center), José M. Moraleda(Centro Regional de Hemodonación), Mareike Verbeek(Technical University of Munich), Peter Dreger(Heidelberg University), Nirav N. Shah(Medical College of Wisconsin), Yener Koç(Antalya IVF), Stefan O. Ciurea(University of California, Irvine), Diderik-Jan Eikema(European Society for Blood and Marrow Transplantation), Wolf Rösler, Stefan Schoenland(Heidelberg University), Didier Blaise(Institut Paoli-Calmettes)
Cited by 27
Related Papers
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718